Edition:
United States

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

135.64USD
23 Feb 2018
Change (% chg)

$1.97 (+1.47%)
Prev Close
$133.67
Open
$134.11
Day's High
$135.68
Day's Low
$133.05
Volume
206,538
Avg. Vol
366,832
52-wk High
$138.40
52-wk Low
$89.25

Select another date:

Thu, Feb 15 2018

BRIEF-Edwards Says Its Self-Expanding Transcatheter Heart Valve Receives CE Mark

* GOT CE MARK FOR SELF-EXPANDING CENTERA VALVE FOR SEVERE, SYMPTOMATIC AORTIC STENOSIS PATIENTS AT HIGH RISK OF OPEN-HEART SURGERY

BRIEF-Edwards Lifesciences Reports Qtrly Adj EPS of $0.94

* EDWARDS LIFESCIENCES QTRLY EARNINGS PER SHARE $0.17; QTRLY ADJUSTED EARNINGS PER SHARE $0.94

BRIEF-Edwards Lifesciences Corp Acquires Harpoon Medical

* EDWARDS LIFESCIENCES CORP - EDWARDS PAID $100 MILLION IN CASH FOR HARPOON AT CLOSING ON DEC. 1

Edwards results fall short of Street estimates; shares tumble

Edwards Lifesciences Corp on Tuesday reported slightly lower-than-expected third-quarter profit and revenue and saw a dip in sales of its critically important transcatheter heart valves from the prior quarter, although they grew about 17 percent from a year earlier.

UPDATE 1-Edwards results fall short of Street estimates; shares tumble

Oct 24 Edwards Lifesciences Corp on Tuesday reported slightly lower-than-expected third-quarter profit and revenue and saw a dip in sales of its critically important transcatheter heart valves from the prior quarter, although they grew about 17 percent from a year earlier.

Edwards 3rd-quarter results short of Street estimates; shares fall

Oct 24 Edwards Lifesciences Corp on Tuesday reported slightly lower-than-expected third-quarter profit and revenue and saw a dip in sales of its critically important transcatheter heart valves from the prior quarter, although they grew about 17 percent from a year earlier.

Select another date: